Myovant Sciences's average Accounts Payable for the
three
months ended in Jun. 2022 was $10.9 Mil. Myovant Sciences's Cost of Goods Sold for the
three
months ended in Jun. 2022 was $22.9 Mil.
Hence, Myovant Sciences's Days Payable for the
three
months ended in Jun. 2022 was 43.38.
The historical rank and industry rank for Myovant Sciences's Days Payable or its related term are showing as below:
MYOV'
s Days Payable Range Over the Past 10 Years
Min: 55.34 Med: 1592.29 Max: 3078.17
Current: 55.34
During the past 7 years, Myovant Sciences's highest Days Payable was 3078.17. The lowest was 55.34. And the median was 1592.29.
MYOV's Days Payable is ranked worse than 70.28% of 683
companies
in the Biotechnology industry
Industry Median: 129.54
vs MYOV: 55.34
Myovant Sciences's Days Payable
declined
from Jun. 2021 (195.25) to Jun. 2022 (43.38).
It may suggest that Myovant Sciences accelerated paying its suppliers.
Myovant Sciences Days Payable Historical Data
The historical data trend for Myovant Sciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Myovant Sciences Annual Data
Trend
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
Days Payable
-
-
-
3,078.17
106.41
Myovant Sciences Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Days Payable
195.25
72.45
58.04
62.70
43.38
Competitive Comparison
For the Biotechnology subindustry, Myovant Sciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Myovant Sciences Days Payable Distribution
For the Biotechnology industry and Healthcare sector, Myovant Sciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Myovant Sciences's Days Payable falls into.
Myovant Sciences Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Myovant Sciences's Days Payable for the fiscal year that ended in Mar. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Myovant Sciences Days Payable Related Terms
Thank you for viewing the detailed overview of Myovant Sciences's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.
Myovant Sciences Ltd is a healthcare company focused on redefining care for women and for men. The company's lead product candidate is relugolix, a once-daily, oral GnRH receptor antagonist. It has three late-stage clinical programs for relugolix in uterine fibroids, endometriosis, and prostate cancer. The company is also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, that has completed a Phase 2a study for the treatment of female infertility as part of assisted reproduction.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.72(4.59%) Volume: 771,873 12:10PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:MYOV has been successfully added to your 
